Related content

A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer

By Esteban E.  

Breast Cancer Research and Treatment, Vol. 62, Iss. 2, 2000-07 ,pp. : 127-133

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel Followed by Epirubicin in Stage II/III Breast Cancer

By Ramaswamy Bhuvaneswari   Povoski Steven   Rhoades Chris   Allen Joan   Hauger Marsha   Young Donn   Burak William   Farrar William   Yee Lisa   Kendra Kari   Somasundaram Sivagurunathan   Orlowski Robert   Shapiro Charles  

Breast Cancer Research and Treatment, Vol. 93, Iss. 1, 2005-09 ,pp. : 67-74

Springer Publishing Company

Access to resources Recommend Favorite

Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer

By Al-Tweigeri Taher   Ajarim Dahish   Alsayed Adher   Rahal Mohamed   Alshabanah Mohamed   Tulbah Asma   Al-Malik Osama   Fatani Doha   El-Husseiny Gamal   Elkum Naser   Ezzat Adnan  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 571-577

Humana Press, Inc

Access to resources Recommend Favorite

Chemo-radiotherapy for Locally Advanced Head and Neck Cancer--Long-term Results of a Phase II Trial

By Dinges S.   Budach V.   Stuschke M.   Budach W.   Boehmer D.   Schrader M.   Jahnke K.   Sack H.  

European Journal of Cancer, Vol. 33, Iss. 7, 1997-06 ,pp. : 1152-1155

Elsevier

Access to resources Recommend Favorite

Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer

By Cooper Brenda   Radivoyevitch Tomas   Overmoyer Beth   Shenk Robert   Pham Huong   Samuels Judith   Parry Margaret   Silverman Paula  

Breast Cancer Research and Treatment, Vol. 97, Iss. 3, 2006-06 ,pp. : 311-318

Springer Publishing Company

Access to resources Recommend Favorite